Comparative assessment of diclofenac removal from water by different microalgae strains

Multi-biomarker response of cyanobacteria Synechocystis salina and Microcystis aeruginosa to diclofenac

The cyanobacterial response to pharmaceuticals is less frequently investigated compared to green algae. Pharmaceuticals can influence not only the growth rate of cyanobacteria culture, but can also cause changes at the cellular level. The effect of diclofenac (DCF) as one of the for cyanobacteria has been rarely tested, and DCF has never been applied with cellular biomarkers. The aim of this work was to test the response of two unicellular cyanobacteria (Synechocystis salina and Microcystis aeruginosa) toward DCF (100 mg L-1) under photoautotrophic growth conditions. Such endpoints were analyzed as cells number, DCF uptake, the change in concentrations of photosynthetic pigments, the production of toxins, and chlorophyll a in vivo fluorescence. It was noted that during a 96 h exposure, cell proliferation was not impacted. Nevertheless, a biochemical response was observed. The increased production of microcystin was noted for M. aeruginosa. Due to the negligible absorption of DCF into cells, it is possible that the biochemical changes are induced by an external signal. The application of non-standard biomarkers demonstrates the effect of DCF on microorganism metabolism without a corresponding effect on biomass. The high resistance of cyanobacteria to DCF and the stimulating effect of DCF on the secretion of toxins raise concerns for environment biodiversity.

Green alga Chlamydomonas reinhardtii can effectively remove diclofenac from the water environment - A new perspective on biotransformation

The use of unicellular algae to remove xenobiotics (including drugs) from wastewaters is one of the rapidly developing areas of environmental protection. Numerous data indicate that for efficient phycoremediation three processes are important, i.e. biosorption, bioaccumulation, and biotransformation. Although biosorption and bioaccumulation do not raise any serious doubts, biotransformation is more problematic since its products can be potentially more toxic than the parent compounds posing a threat to organisms living in a given environment, including organisms that made this transformation. Thus, two questions need to be answered before the proper algae strain is chosen for phycoremediation, namely what metabolites are produced during biotransformation, and how resistant is the analyzed strain to a mixture of parent compound and metabolites that appear over the course of culture? In this work, we evaluated the remediation potential of the model green alga Chlamydomonas reinhardtii in relation to non-steroidal anti-inflammatory drugs (NSAIDs), as exemplified by diclofenac. To achieve this, we analysed the susceptibility of C. reinhardtii to diclofenac as well as its capability to biosorption, bioaccumulation, and biotransformation of the drug. We have found that even at a relatively high concentration of diclofenac the algae maintained their vitality and were able to remove (37.7%) DCF from the environment. A wide range of phase I and II metabolites of diclofenac (38 transformation products) was discovered, with many of them characteristic rather for animal and bacterial biochemical pathways than for plant metabolism. Due to such a large number of detected products, 18 of which were not previously reported, the proposed scheme of diclofenac transformation by C. reinhardtii not only significantly contributes to broadening the knowledge in this field, but also allows to suggest possible pathways of degradation of xenobiotics with a similar structure. It is worth pointing out that a decrease in the level of diclofenac in the media observed in this study cannot be fully explained by biotransformation (8.4%). The mass balance analysis indicates that other processes (total 22%), such as biosorption, a non-extractable residue formation, or complete decomposition in metabolic cycles can be involved in the diclofenac disappearance, and those findings open the prospects of further research.

Emerging contaminants in the aquatic environment: phytoplankton structure in the presence of sulfamethoxazole and diclofenac

Chemicals from anthropogenic activities such as domestic sewage, pesticide leaching, and improper chemical disposal have caused groundwater contamination. The presence of these emerging contaminants in the aquatic environment can change water quality and biota composition. Thus, this study investigates the effect of two emerging contaminants, anti-inflammatory drug diclofenac (DCF) and antibiotic sulfamethoxazole (SMX), on the aquatic environment, evaluating the phytoplankton community structure. A microcosm experiment was conducted with 16 sampling units, each one with 500 mL of water sample containing phytoplankton exposed to these drugs at different concentrations (0.1, 0.5, and 1.0 mg L-1). The experiment lasted 15 days, and samples were collected on days 0, 3, 5, 7, and 14 to evaluate the phytoplankton community, the concentrations of the drugs, and the nutrients in the samples. Six phytoplankton groups were identified, and diatoms and green algae were the most diverse and abundant groups. For the entire community, we identified differences between the days of the experiment, varying in the diversity and density of organisms, but not between the concentrations of the two drugs. Evaluating the groups separately, we identified differences in the abundance of cyanobacteria for the treatment with diclofenac and desmids for the treatment with sulfamethoxazole. We demonstrated that the presence of pharmaceuticals in freshwater ecosystems can somehow affect the phytoplankton community, especially the diversity and abundance of cyanobacteria and desmids. Therefore, our study indicates the importance of evaluating the presence of pharmaceuticals in freshwater ecosystems and their influence on aquatic organisms, as well as pharmaceuticals may be changing the structure of the aquatic environment.

Water stable MOFs as emerging class of porous materials for potential environmental applications

Metal-organic frameworks (MOFs) are extensively recognized for their wide applications in a variety of fields such as water purification, adsorption, sensing, catalysis and drug delivery. The fundamental characteristics of the majority of MOFs, such as their structure and shape, are known to be sensitively impacted by water or moisture. As a result, a thorough evaluation of the stability of MOFs in respect to factors linked to these property changes is required. It is quite rare for MOFs in their early stages to have strong water-stability, which is necessary for the commercialization and development of wider applications of this interesting material. Also, numerous applications in presence of water have progressed considerably as a "proof of concept" stage in the past and a growing number of water-stable MOFs (WSMOFs) have been discovered in recent years. This review discusses the variables and processes that affect the aqueous stability of several MOFs, including imidazolate and carboxylate frameworks. Accordingly, this article will assist researchers in accurately evaluating how water affects the stability of MOFs so that effective techniques can be identified for the advancement of water-stable metal-organic frameworks (WSMOFs) and for their effective applications toward a variety of fields.

Pharmaceutical residues: One of the significant problems in achieving 'clean water for all' and its solution

With the rapid emergence of various metabolic and multiple-drug-resistant infectious diseases, new pharmaceuticals are continuously being introduced in the market. The excess production and use of pharmaceuticals and their untreated/unmetabolized release in the environment cause the contamination of aquatic ecosystem, and thus, compromise the environment and human-health. The present review provides insights into the classification, sources, occurrence, harmful impacts, and existing technologies to curb these problems. A comprehensive detail of various biological and nanotechnological strategies for the removal of pharmaceutical residues from water is critically discussed focusing on their efficiencies, and current limitations to design improved-technologies for their lab-to-field applications. Furthermore, the review highlights and suggests the scope of integrated bionanotechnological methods for enhanced removal of pharmaceutical residues from water to fulfill the United Nations Sustainable Development Goal (UN-SDG) for providing clean potable water for all.

Mechanisms and application of microalgae on removing emerging contaminants from wastewater: A review

This study reviews the development of the ability of microalgae to remove emerging contaminants (ECs) from wastewater. Contaminant removal by microalgae-based systems (MBSs) includes biosorption, bioaccumulation, biodegradation, photolysis, hydrolysis, and volatilization. Usually, the existence of ECs can inhibit microalgae growth and reduce their removal ability. Therefore, three methods (acclimation, co-metabolism, and algal-bacterial consortia) are proposed in this paper to improve the removal performance of ECs by microalgae. Finally, due to the high removal performance of contaminants from wastewater by algal-bacterial consortia systems, three kinds of algal-bacterial consortia applications (algal-bacterial activatedsludge, algal-bacterial biofilm reactor, and algal-bacterial constructed wetland system) are recommended in this paper. These applications are promising for ECs removal. But most of them are still in their infancy, and limited research has been conducted on operational mechanisms and removal processes. Extra research is needed to clarify the applicability and cost-effectiveness of hybrid processes.

Removal processes of individual and a mixture of organic micropollutants in the presence of Scenedesmus obliquus

Organic micropollutants (OMPs) need to be removed from wastewater as they can negatively affect aquatic organisms. It has been demonstrated that microalgae-based technologies are efficient in removing OMPs from wastewater. In this study, the removal processes and kinetics of six persistent OMPs (diclofenac, clarithromycin, benzotriazole, metoprolol, carbamazepine and mecoprop) were studied during cultivation of Scenedesmus obliquus in batch mode. These OMPs were added as individual compounds and in a mixture. Short experiments (8 days) were performed to avoid masking of OMP removal processes by light and nutrient limitation. The results show that diclofenac, clarithromycin, and benzotriazole were mainly removed by photodegradation (diclofenac), biodegradation (benzotriazole), or a combination of these two processes (clarithromycin). Peroxidase was involved in intracellular and extracellular biodegradation when benzotriazole was present as individual compound. Carbamazepine, metoprolol and mecoprop showed no biodegradation or photodegradation, and neglectable removal (<5%) by bioadsorption and bioaccumulation. Using an OMP mixture had an adverse effect on the photodegradation of clarithromycin and diclofenac, with reduced first-order kinetic constants compared to the individual compounds. Benzotriazole biodegradation was inhibited by the presence of the OMP mixture. This indicates that the presence of OMPs inhibits the photodegradation and biodegradation of some individual OMPs. These results will improve our understanding of removal processes of individual and mixtures of OMPs by microalgae-based technologies for wastewater treatment.

Pharmaceuticals in the Aquatic Environment: A Review on Eco-Toxicology and the Remediation Potential of Algae

The pollution of the aquatic environment has become a worldwide problem. The widespread use of pesticides, heavy metals and pharmaceuticals through anthropogenic activities has increased the emission of such contaminants into wastewater. Pharmaceuticals constitute a significant class of aquatic contaminants and can seriously threaten the health of non-target organisms. No strict legal regulations on the consumption and release of pharmaceuticals into water bodies have been implemented on a global scale. Different conventional wastewater treatments are not well-designed to remove emerging contaminants from wastewater with high efficiency. Therefore, particular attention has been paid to the phycoremediation technique, which seems to be a promising choice as a low-cost and environment-friendly wastewater treatment. This technique uses macro- or micro-algae for the removal or biotransformation of pollutants and is constantly being developed to cope with the issue of wastewater contamination. The aims of this review are: (i) to examine the occurrence of pharmaceuticals in water, and their toxicity on non-target organisms and to describe the inefficient conventional wastewater treatments; (ii) present cost-efficient algal-based techniques of contamination removal; (iii) to characterize types of algae cultivation systems; and (iv) to describe the challenges and advantages of phycoremediation.

Combined Process of Biogenic Manganese Oxide and Manganese-Oxidizing Microalgae for Improved Diclofenac Removal Performance: Two Different Kinds of Synergistic Effects

Biogenic manganese oxides (Bio-MnOx) have attracted considerable attention for removing pharmaceutical contaminants (PhCs) due to their high oxidation capacity and environmental friendliness. Mn-oxidizing microalgae (MnOMs) generate Bio-MnOx with low energy and organic nutrients input and degrade PhCs. The combined process of MnOMs and Bio-MnOx exhibits good prospects for PhCs removal. However, the synergistic effects of MnOMs and Bio-MnOx in PhCs removal are still unclear. The performance of MnOMs/Bio-MnOx towards diclofenac (DCF) removal was evaluated, and the mechanism was revealed. Our results showed that the Bio-MnOx produced by MnOMs were amorphous nanoparticles, and these MnOMs have a good Mn²⁺ tolerance and oxidation efficiency (80–90%) when the Mn²⁺ concentration is below 1.00 mmol/L. MnOMs/Bio-MnOx significantly promotes DCF (1 mg/L) removal rate between 0.167 ± 0.008 mg/L·d (by MnOMs alone) and 0.125 ± 0.024 mg/L·d (by Bio-MnOx alone) to 0.250 ± 0.016 mg/L·d. The superior performance of MnOMs/Bio-MnOx could be attributed to the continuous Bio-MnOx regeneration and the sharing of DCF degradation intermediates between Bio-MnOx and MnOMs. Additionally, the pathways of DCF degradation by Bio-MnOx and MnOMs were proposed. This work could shed light on the synergistic effects of MnOMs and Bio-MnOx in PhCs removal and guide the development of MnOMs/Bio-MnOx processes for removing DCF or other PhCs from wastewater.

Bioremediation of phenolic pollutants by algae - current status and challenges

Industrial production processes, especially petroleum processing, will produce high concentration phenolic wastewater. Traditional wastewater treatment technology is costly and may lead to secondary pollution. In order to avoid the adverse effects of incompletely treated phenolics, more advanced methods are required. Algae bioremediate phenolics through green pathways such as adsorption, bioaccumulation, biodegradation, and photodegradation. At the same time, the natural carbon fixation capacity of algae and its potential to produce high-value products make algal wastewater treatment technology economically feasible. This paper reviews the environmental impact of several types of phenolic pollutants in wastewater and different strategies to improve bioremediation efficiency. This paper focuses on the progress of algae removing phenols by different mechanisms and the potential of algae biomass for further biofuel production. This technology holds great promise, but more research on practical wastewater treatment at an industrial scale is needed in the future.

Biodegradation of pharmaceuticals in photobioreactors - a systematic literature review

This work is a systematic review that reports state-of-the-art in removal of pharmaceuticals from water and wastewater by photosynthetic organisms in photobioreactors. The PRISMA protocol-based review of the most recent literature data from the last 10 years (2011–2021) was reported. Articles were searched by the combination of the following keywords: photobioreactor, pharmaceuticals, drugs, hormones, antibiotics, biodegradation, removal, wastewater treatment. The review focuses on original research papers (not reviews), collected in 3 scientific databases: Scopus, Web of Knowledge, PubMed. The review considered the following factors: type of microorganisms, type of micropollutants removed, degradation efficiency and associated products, types of photosynthetic organisms and photobioreactor types. The conclusion from the systematic review is that the main factors that limit widespread pharmaceuticals removal in photobioreactors are high costs and the problem of low efficiency related with low concentrations of pharmaceuticals. The review indicated a need for further research in this area due to increasing amounts of metabolites in the food chain, such as p-aminophenol and estrone, which can cause harm to people and ichthyofauna. Pharmaceuticals removal can be improved by adapting the type of microorganism used to the type of contamination and implementing photoperiods, which increase the removal efficiency of e.g. sulfamethazine by up to 28%. In the future, it is necessary to search for new solutions in terms of the construction of photobioreactors, as well as for more effective species in terms of pharmaceuticals biodegradation that can survive the competition with other strains during water and wastewater treatment.

Microalgal-based removal of contaminants of emerging concern

The presence of contaminants of emerging concern (CECs) in the environment has been recognized as a worldwide concern. In particular, water pollution by CECs is becoming a major global problem, which requires ongoing evaluation of water resources policies at all levels and the use of effective and innovative wastewaters treatment processes for their removal. Microalgae have been increasingly recognized as relevant for wastewater polishing, including CECs removal. These microorganisms are commonly cultivated in suspension. However, the use of planktonic microalgae for wastewater treatment has limitations in terms of microbiological contamination, process effectiveness and sustainability. The use of consortia of microalgae and bacteria represents a significant advance for sustainable wastewater polishing, particularly when the microorganisms are associated as biofilms. These immobilized mixed cultures can overcome the limitations of suspended-microalgae systems and improve the performance of the involved species for CECs removal. In addition, microalgae-bacteria based systems can offer a relevant combined effect for CECs removal and biomass production enhancement. This study reviews the advantages and advances on the use of microalgae for wastewater treatment, highlighting the potential on the use of microalgae-bacteria biofilms for CECs removal and the further biomass valorisation for third-generation biofuel production.

Evaluation of an outdoor pilot-scale tubular photobioreactor for removal of selected pesticides from water

This work assesses the capacity of a microalgae-based system to remove three highly to medium polar pesticides typically found in freshwater: acetamiprid, bentazone, and propanil. Degradation of the pesticides was firstly studied individually at batch lab-scale reactors and abiotic and heated-killed controls were employed to clarify their removal pathways. At lab-scale, propanil and acetamiprid were completely removed after 7 days whereas bentazone was not removed. Four and two transformation products (TPs) were generated in the biodegradation process for acetamiprid and propanil, respectively. Then, the simultaneous removal of the pesticides was assessed in an outdoor pilot photobioreactor, operated with a hydraulic residence time of 8 days. During the steady-state, high removal efficiencies were observed for propanil (99%) and acetamiprid (71%). The results from batch experiments suggest that removal is mainly caused by algal-mediated biodegradation. Acetamiprid TPs raised throughout the operational time in the photobioreactor, while no propanil TP was detected at the pilot-scale. This suggests complete mineralization of propanil or residual formation of its TPs at concentrations below the analytical method detection limit. Aiming at biomass valorization, diverse microalgae harvesting methods were investigated for biomass concentration, and the effect of residual pesticides on the biogas yield was determined by biochemical methane potential tests. Anaerobic digestion was not inhibited by the pesticides as verified by the digestion performance. The results highlight the potential of microalgae-based systems to couple nutrient removal, biomass production, micropollutant biodegradation, and biofuel production.

Current perspective of innovative strategies for bioremediation of organic pollutants from wastewater

Organic contaminants in water are a growing environmental threat to sustainable development, with detrimental effects on the biosphere. In recent years, researchers have increasingly focused their attention on the area of bioremediation as an important tool to eliminate harmful pollutants from the environment. This review examines the application of bioremediation technologies to the removal of organic pollutants, with an emphasis on hydrocarbons and textile dyes. It applies a descriptive bibliometric analysis to study statistical practicality-vs-applicability of bioremediation of emerging organic pollutants. The paper identifies efficient pathways for bioremediation of different types of organic pollutants and outlines the potential for an eco-friendly and economical approach for the biological remediation of micropollutants by microalgae. Facts and figures on various hazardous pollutants, constraints in their current removal from water at an industrial level, and promising future solutions are carefully presented here.

Applications of water-stable metal-organic frameworks in the removal of water pollutants: A review

Because the pollutants produced by human activities have destroyed the ecological balance of natural water environment, and caused severe impact on human life safety and environmental security. Hence the task of water environment restoration is imminent. Metal-organic frameworks (MOFs), structured from organic ligands and inorganic metal ions, are notable for their outstanding crystallinity, diverse structures, large surface areas, adsorption performance, and excellent component tunability. The water stability of MOFs is a key requisite for their possible actual applications in separation, catalysis, adsorption, and other water environment remediation areas because it is necessary to safeguard the integrity of the material structure during utilization. In this article, we comprehensively review state-of-the-art research progress on the promising potential of MOFs as excellent nanomaterials to remove contaminants from the water environment. Firstly, the fundamental characteristics and preparation methods of several typical water-stable MOFs include UiO, MIL, and ZIF are introduced. Then, the removal property and mechanism of heavy metal ions, radionuclide contaminants, drugs, and organic dyes by different MOFs were compared. Finally, the application prospect of MOFs in pollutant remediation prospected. In this review, the synthesis methods and application in water pollutant removal are explored, which provide ways toward the effective use of water-stable MOFs in materials design and environmental remediation.

Microalgal Systems for Wastewater Treatment: Technological Trends and Challenges towards Waste Recovery

Wastewater (WW) treatment using microalgae has become a growing trend due the economic and environmental benefits of the process. As microalgae need CO2, nitrogen, and phosphorus to grow, they remove these potential pollutants from wastewaters, making them able to replace energetically expensive treatment steps in conventional WW treatment. Unlike traditional sludge, biomass can be used to produce biofuels, biofertilizers, high value chemicals, and even next-generation growth media for “organically” grown microalgal biomass targeting zero-waste policies and contributing to a more sustainable circular bioeconomy. The main challenge in this technology is the techno-economic feasibility of the system. Alternatives such as the isolation of novel strains, the use of native consortia, and the design of new bioreactors have been studied to overcome this and aid the scale-up of microalgal systems. This review focuses on the treatment of urban, industrial, and agricultural wastewaters by microalgae and their ability to not only remove, but also promote the reuse, of those pollutants. Opportunities and future prospects are discussed, including the upgrading of the produced biomass into valuable compounds, mainly biofuels.

Hazardous impact of diclofenac on mammalian system: Mitigation strategy through green remediation approach

Diclofenac is an anti-inflammatory drug used as an analgesic. It is often detected in various environmental sources around the world and is considered as one of the emerging contaminants (ECs). This paper reviews the distribution of diclofenac at high concentrations in diverse environments and its adverse ecological impact. Recent studies observed strong evidence of the hazardous effect of diclofenac on mammals, including humans. Diclofenac could cause gastrointestinal complications, neurotoxicity, cardiotoxicity, hepatotoxicity, nephrotoxicity, hematotoxicity, genotoxicity, teratogenicity, bone fractures, and skin allergy in mammals even at a low concentration. Collectively, this comprehensive review relates the mode of toxicity, level of exposure, and route of administration as a unique approach for addressing the destructive consequence of diclofenac in mammalian systems. Finally, the mitigation strategy to eradicate the diclofenac toxicity through green remediation is critically discussed. This review will undoubtedly shed light on the toxic effects of pseudo-persistent diclofenac on mammals as well as frame stringent guidelines against its common usage.

Specific toxicity of azithromycin to the freshwater microalga Raphidocelis subcapitata

Pharmaceuticals are produced to inflict a specific physiological response in organisms. However, as only partially metabolized after administration, these types of compounds can also originate harmful side effects to non-target organisms. Additionally, there is still a lack of knowledge on the toxicological effects of legacy pharmaceuticals such as the antibiotic azithromycin. This macrolide occurs at high concentrations in the aquatic environment and can constitute a threat to aquatic organisms that are at the basis of the aquatic food chain, namely microalgae. This study established a high-throughput methodology to study the toxicity of azithromycin to the freshwater microalga Raphidocelis subcapitata. Flow cytometry and pulse amplitude modulated (PAM) fluorometry were used as screening tools. General toxicity was shown by effects in growth rate, cell size, cell complexity, cell viability and cell cycle. More specific outcomes were indicated by the analysis of mitochondrial and cytoplasmatic membrane potentials, DNA content, formation of ROS and LPO, natural pigments content and photosystem II performance. The specific mode of action (MoA) of azithromycin to crucial components of microalgae cells was revealed. Azithromycin had a negative impact on the regulation of energy dissipation at the PSII centers, along with an insufficient protection by the regulatory mechanisms leading to photodamage. The blockage of photosynthetic electrons led to ROS formation and consequent oxidative damage, affecting membranes and DNA. Overall, the used methodology exhibited its high potential for detecting the toxic MoA of compounds in microalgae and should be considered for future risk assessment of pharmaceuticals.

Potential of Microalgae in Bioremediation of Wastewater

The increase in global pollution, industrialization and fast economic progress are considered to inflict serious consequences to the quality and availability of water throughout the world. Wastewater is generated from three major sources, i.e. industrial, agricultural, and municipal which contain pollutants, such as: xenobiotics, microplastics, heavy metals and augmented by high amount of carbon, phosphorus, and nitrogen compounds. Wastewater treatment is one of the most pressing issues since it cannot be achieved by any specific technology because of the varying nature and concentrations of pollutants and efficiency of the treatment technologies. The degradation capacity of these conventional treatment technologies is limited, especially regarding heavy metals, nutrients, and xenobiotics, steering the researchers to bioremediation using microalgae (Phycoremediation). Bioremediation can be defined as use of microalgae  for removal or biotransformation of pollutants and CO2 from wastewater with concomitant biomass production. However, the usage of wastewaters for the bulk cultivation of microalgae is advantageous for reducing carbon, nutrients cost, minimizing the consumption of freshwater, nitrogen, phosphorus recovery, and removal of other pollutants from wastewater and producing sufficient biomass for value addition for either biofuels or other value-added compounds. Several types of microalgae like Chlorella and Dunaliella have proved their applicability in the treatment of wastewaters. The bottlenecks concerning the microalgal wastewater bioremediation need to be identified and elucidated to proceed in bioremediation using microalgae. This objective of this paper is to provide an insight about the treatment of different wastewaters using microalgae and microalgal potential in the treatment of wastewaters containing heavy metals and emerging contaminants, with the specialized cultivation systems. This review also summarizes the end use applications of microalgal biomass which makes the bioremediation aspect more environmentally sustainable. Copyright © 2021 by Authors, Published by BCREC Group. This is an open access article under the CC BY-SA License (https://creativecommons.org/licenses/by-sa/4.0). 

Current advances in microalgae-based bioremediation and other technologies for emerging contaminants treatment

Emerging contaminants (EC) have been detected in effluents and drinking water in concentrations that can harm to a variety of organisms. Therefore, several technologies are developed to treat these compounds, either for their complete removal or degradation in less toxic by-products. Some technologies applied to the treatment of EC, such as adsorption, advanced oxidative processes, membrane separation processes, and bioremediation through microalgal metabolism, were identified by thematic maps. In this review, we used a bibliometric software from >1000 articles. These manuscripts, in general, present removals from 0% to 100% for different ECs. This efficiency varies between treatment technologies and the contaminants' physical-chemical properties and their concentration and operational parameters. This review explored the bioremediation of EC through microalgae with greater emphasis. The main mechanisms of action of microalgae in the bioremediation of ECs are biodegradation bioadsorption, and bioaccumulation. Also, physicochemical properties and removal efficiencies of >50 emerging contaminants are presented. Although there are challenges related to the generation of more toxic by-products and economic and environmental viability, these can be minimized with advances in the development of treatment technologies and even through the integration of different techniques to make the treatment of contaminants emerging from environmental media more sustainable.

Enhancement of nutrients removal and biomass accumulation of Chlorella vulgaris in pig manure anaerobic digestate effluent by the pretreatment of indigenous bacteria

High concentrations of pollutants in pig manure anaerobic digestate effluent (PMADE) can severely inhibit microalgal growth. In this study, two types of PMADE (PMADE-1, PMADE-2) were pretreated with indigenous bacteria which were selected from PMADE to alleviate their inhibition for the growth of Chlorella vulgaris. Indigenous bacteria could decrease 34.04% and 47.80% of total phosphorus (TP) and turbidity in PMADE-1, and 80.81%, 43.27%, and 57.51% of COD, TP, and turbidity in PMADE-2, respectively. And no significant reduction of NH₄⁺-N in both PMADE after 5 days pretreatment occurred. C. vulgaris failed to grow in unpretreated PMADE-2. Pretreatment of PMADE with indigenous bacteria could remarkably promote nutrients removal and cell growth of C. vulgaris compared to the unpretreated PMADE. The order of abiotic stress in the studied PMADE was COD > NH₄⁺-N > turbidity, and it is appropriate to pretreat the PMADE with indigenous bacteria for 2-3 days.

Removal of pharmaceutical and personal care products (PPCPs) from wastewater using microalgae: A review

Pharmaceuticals and personal care products (PPCPs) are a group of emerging micro-pollutants causing detrimental effects on living organisms even at low doses. Previous investigations have confirmed the presence of PPCPs in the environment at hazardous levels, mainly due to the inefficiency of conventional wastewater treatment plants (CWWTPs). Their stable structure induces longer persistence in the environment. Microalgae are currently used to bioremediate numerous pollutants of different characteristics and properties released from the domestic, industrial, agricultural, and farm sectors. CO₂ mitigation during culture and the use of biomass as feedstock for biodiesel or biofuel production are, briefly, other benefits of microalgae-mediated treatment over CWWTPs. This review provides a comprehensive summary of recent literature, an overview of approaches and treatment systems, and breakthrough in the field of algal-mediated removal of PPCPs in wastewater treatment processes. The mechanisms involved in phycoremediation, along with their experimental approaches, have been discussed in detail. Factors influencing the removal of PPCPs from aqueous media are comprehensively described and assessed. A comparative study on microalgal strains is analyzed for a more efficient implementation of future processes. The role of microalgae to mitigate the most severe environmental impacts of PPCPs and the generation of antibiotic-resistant bacteria is discussed. Also, a detailed assessment of recent research on potential toxic effects of PPCPs on microalgae was conducted. The current review highlights microalgae as a promising and sustainable approach to efficiently bio-transform or bio-adsorb PPCPs.

Green Microalgae Scenedesmus Obliquus Utilization for the Adsorptive Removal of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) from Water Samples

In view of the valorisation of the green microalga Scenedesmus obliquus biomass, it was used for the biosorption of two nonsteroidal anti-inflammatory drugs, namely salicylic acid and ibuprofen, from water. Microalgae biomass was characterized, namely by the determination of the point of zero charge (pH_PZC), by Fourier transform infrared (FT-IR) analysis, simultaneous thermal analysis (STA) and scanning electron microscopy with energy dispersive spectroscopy (SEM/EDS). Kinetic and equilibrium batch experiments were carried out and results were found to fit the pseudo-second order equation and the Langmuir isotherm model, respectively. The Langmuir maximum capacity determined for salicylic acid (63 mg g⁻¹) was larger than for ibuprofen (12 mg g⁻¹), which was also verified for a commercial activated carbon used as reference (with capacities of 250 and 147 mg g⁻¹, respectively). For both pharmaceuticals, the determination of thermodynamic parameters allowed us to infer that adsorption onto microalgae biomass was spontaneous, favourable and exothermic. Furthermore, based on the biomass characterization after adsorption and energy associated with the process, it was deduced that the removal of salicylic acid and ibuprofen by Scenedesmus obliquus biomass occurred by physical interaction.

Mechanism and kinetics of methylisothiazolinone removal by cultivation of Scenedesmus sp. LX1

Methylisothiazolinone (MIT) is a widely used non-oxidizing biocide for membrane biofouling control in reverse osmosis (RO) systems usually with high dosages. However, few investigations have focused on MIT removal through bio-processes, since it is highly bio-toxic. This study proposed a novel biotreatment approach for efficient MIT degradation by Scenedesmus sp. LX1, a microalga with strong resistance capability against extreme MIT toxicity. Results showed that MIT (3 mg/L) could be completely removed within 4 days' cultivation with a half-life of only 0.79 d. Biodegradation was the primary removal mechanism and this metabolic process did not rely on bacterial consortia, soluble algal products secretion or algal growth. The main pathway was proposed as ring cleavage followed by methylation and carboxylation through the identification of MIT transformation products. MIT biodegradation followed the pseudo-first-order kinetics under growth control. A new kinetic model was presented to depict the MIT removal considering algal growth, and this model could be used for generally describing non-nutritive contaminants biodegradation. The algal biodegradation capability was independent of the initial biocide concentration, and MIT removal could be enhanced by increasing the initial algal density. Our results highlight the potential application of algal cultivation for MIT-containing wastewater biotreatment, such as RO concentrate.

Acetaminophen Removal from Water by Microalgae and Effluent Toxicity Assessment by the Zebrafish Embryo Bioassay

In this work, zebrafish embryo bioassays were performed to assess the efficiency of microalgae in the removal of acetaminophen from water. Chlorella sorokiniana (CS), Chlorella vulgaris (CV) and Scenedesmus obliquus (SO) were the strains used for water treatment. Toxic effects on zebrafish embryo caused by effluents from microalgae treatment were compared with those observed under exposure to experimental solutions with known concentrations of acetaminophen. The three microalgae strains allowed for the reduction of acetaminophen concentration and its toxic effects, but CS was the most efficient one. At the end of the batch culture, a 67% removal was provided by CS with a reduction of 62% in the total abnormalities on the exposed zebrafish embryo. On the other hand, toxic effects observed under exposure to effluents treated by microalgae were alike to those determined for acetaminophen experimental solutions with equivalent concentration. Thus, it may be inferred that microalgae biodegradation of acetaminophen did not involve an increased toxicity for zebrafish embryo.

Comparative Thermogravimetric Assessment on the Combustion of Coal, Microalgae Biomass and Their Blend

In this work, thermogravimetric analysis (TGA), differential thermogravimetry (DTG), and differential scanning calorimetric (DSC) were used to assess the combustion of microalgae biomass, a bituminous coal, and their blend. Furthermore, different correlations were tested for estimating the high heating value of microalgae biomass and coal, with both materials possessing similar values. TGA evidenced differences between the combustion of the studied fuels, but no relevant interaction occurred during their co-combustion, as shown by the DTG and DSC curves. These curves also indicated that the combustion of the blend mostly resembled that of coal in terms of weight loss and heat release. Moreover, non-isothermal kinetic analysis revealed that the apparent activation energies corresponding to the combustion of the blend and coal were quite close. Overall, the obtained results indicated that co-combustion with coal might be a feasible waste to energy management option for the valorization of microalgae biomass resulting from wastewater treatment.

The light-dependent lethal effects of 1,2-benzisothiazol-3(2H)-one and its biodegradation by freshwater microalgae

As 1,2-benzisothiazol-3(2H)-one (BIT) has been widely used in high concentrations for microbial growth control in many domestic and industrial processes, its potential eco-risk should be assessed. This study investigated the interaction between BIT and microalgae in aquatic environment as the mechanism of BIT lethal effect on microalgae was unclear and whether microalgae could efficiently remove BIT was unknown. It was found that Chlorella vulgaris could be killed by high concentrations of BIT, and this lethal effect was strongly enhanced when exposed to light. Inhibition of photosystem II electron transport followed by a decrease in cellular chlorophyll led to serious damage to algal photosynthesis. The excess accumulation of reactive oxygen species caused by the photosynthetic damage under light further increased the oxidative damage and promoted cell death. Under dark condition, however, the algae could tolerate higher BIT concentrations. BIT could be efficiently removed when the growth of Scenedesmus sp. LX1 was not completely inhibited. With an initial concentration of 4.5 mg/L, over 99% of BIT was removed during 168 hour cultivation. Microalgal biodegradation was the primary reason for this removal, and the contributions of BIT hydrolytic/photolytic degradation, microalgal growth, photosynthesis and sorption were negligibly small. These results pointed to the potential application of microalgae for efficient BIT removal from wastewater.

Effect of PHRs and PCPs on Microalgal Growth, Metabolism and Microalgae-Based Bioremediation Processes: A Review

In this review, the effect of pharmaceuticals (PHRs) and personal care products (PCPs) on microalgal growth and metabolism is reported. Concentrations of various PHRs and PCPs that cause inhibition and toxicity to growths of different microalgal strains are summarized and compared. The effect of PHRs and PCPs on microalgal metabolism (oxidative stress, enzyme activity, pigments, proteins, lipids, carbohydrates, toxins), as well as on the cellular morphology, is discussed. Literature data concerning the removal of PHRs and PCPs from wastewaters by living microalgal cultures, with the emphasis on microalgal growth, are gathered and discussed. The potential of simultaneously bioremediating PHRs/PCPs-containing wastewaters and cultivating microalgae for biomass production in a single process is considered. In the light of reviewed data, the feasibility of post-bioremediation microalgal biomass is discussed in terms of its contamination, biosafety and further usage for production of value-added biomolecules (pigments, lipids, proteins) and biomass as a whole.

Algal-based removal strategies for hazardous contaminants from the environment - A review

Owing to the controlled or uncontrolled industrial wastewater disposal, pharmaceutical-based hazardous emerging contaminants (ECs) can be found in the environment all over the world. With ever-increasing socioeconomic aspects and environmental awareness, people are now more concerns about the widespread occurrences of hazardous and persistent contaminants, around the globe. In this context, several studies have already shown that various types of emerging and/or re-emerging contaminants, regardless the source, type and concentration, are of supreme threat to the living system of flora and fauna. Recently, algae-based bioreactors have gained special research interest as a promising way to remove pharmaceuticals-based ECs from the wastewater either partially or completely. This paper covers the progress on the removal of selected pharmaceuticals using bioreactors. In laboratory scale studies, high removal percentages have been reached for most selected pharmaceuticals, but data on full-scale bioreactors is limited. In this paper, two types of bioreactors are discussed, i.e., (1) open pond and (2) bubble column photobioreactor, which are considered sustainable and an effective alternative to remove ECs. In these bioreactors, high removal percentages (>90%) have been found for metoprolol, triclosan, and salicylic acid, moderate (50-90%) for carbamazepine and tramadol and very low (<10%) for trimethoprim and ciprofloxacin by inoculating different microalgae. This technique may open new opportunities for the treatment of wastewater and reduce the environmental pollution that can have adverse effects on the ecosystem and human health. In summary, the present review focuses on the microalgae for wastewater remediation. An effort has also been made to describe the generalities of the photobioreactor.

Efficient adsorption of diclofenac sodium from aqueous solutions using magnetic amine-functionalized chitosan

In this study, we prepared a magnetic composite based on amine-functionalized chitosan (aminochitosan; AmCS) and Fe₃O₄ to remove diclofenac sodium (DS) from water. The fabricated AmCS@Fe₃O₄ composite was characterized using Fourier-transform infrared spectroscopy, transmission electron microscopy, scanning electron microscopy, vibrating sample magnetometry, X-ray diffraction, and thermogravimetric analysis. Furthermore, we investigated the influence of pH, initial DS concentration, and adsorbent dosage on the adsorption of DS. Through thermodynamic analysis, we found that the data corresponded with the Langmuir adsorption isotherm model. The maximum adsorption capacity reached 469.48 mg g^-1, and the adsorption process followed the pseudo-second-order kinetic model. Finally, the AmCS@Fe₃O₄ composite retained good adsorption characteristics after four consecutive cycles, with removal efficiency exceeding 70%. Therefore, the developed adsorbent could be used for efficient adsorptive removal of trace drugs and personal care products from water bodies.

Zebrafish embryo bioassays for a comprehensive evaluation of microalgae efficiency in the removal of diclofenac from water

This work deals with a preliminary study aimed at evaluating the efficiency of three different microalgae strains, namely Chlorella sorokiniana, Chlorella vulgaris and Scenedesmus obliquus in the bioremediation of diclofenac contaminated water. For this purpose, microalgae were cultured in bubbling column photobioreactors (PBRs) under batch operation until the end of the exponential growth phase. For the three strains, the concentration of diclofenac in the PBRs aquatic medium decreased along microalgae growing, which pointed to biodegradation as the main removal mechanism. Among the three strains, S. obliquus was the most capable to reduce diclofenac concentration (99% removal from an initial concentration of 25,000 μg l^-1). However, such a large removal does not guarantee an efficient treatment since transformation products (TPs) exceeding the concentration and/or toxicity of the parent compound may be generated during biodegradation of diclofenac. Thus, for a comprehensive evaluation of the microalgae treatments efficiency, the final effluents from the PBRs were tested for their effects on the embryonic development of zebrafish. Again, the S. obliquus treatment was the most efficient in the reduction of toxicity, with the corresponding effluents having no effects on the embryo's mortality or abnormalities incidence (at 80 h post fertilization). In any case, for the three strains, the toxicity effects of effluents were equal or lower than those determined for diclofenac solutions with the same concentration. Therefore, it may be stated that, at the end of the batch culture, the removal of diclofenac by the considered strains did not involve the generation of toxic TPs to zebrafish embryos.

Utilization of Non-Living Microalgae Biomass from Two Different Strains for the Adsorptive Removal of Diclofenac from Water

In the present work, the adsorptive removal of diclofenac from water by biosorption onto non-living microalgae biomass was assessed. Kinetic and equilibrium experiments were carried out using biomass of two different microalgae strains, namely Synechocystis sp. and Scenedesmus sp. Also, for comparison purposes, a commercial activated carbon was used under identical experimental conditions. The kinetics of the diclofenac adsorption fitted the pseudo-second order equation, and the corresponding kinetic constants indicating that adsorption was faster onto microalgae biomass than onto the activated carbon. Regarding the equilibrium results, which mostly fitted the Langmuir isotherm model, these pointed to significant differences between the adsorbent materials. The Langmuir maximum capacity (Qmax) of the activated carbon (232 mg∙g−1) was higher than that of Scenedesmus sp. (28 mg∙g−1) and of Synechocystis sp. (20 mg∙g−1). In any case, the Qmax values determined here were within the values published in the recent scientific literature on the utilization of different adsorbents for the removal of diclofenac from water. Still, Synechocystis sp. showed the largest KL fitted values, which points to the affinity of this strain for diclofenac at relative low equilibrium concentrations in solution. Overall, the results obtained point to the possible utilization of microalgae biomass waste in the treatment of water, namely for the adsorption of pharmaceuticals.

Removal of pharmaceuticals in urban wastewater: High rate algae pond (HRAP) based technologies as an alternative to activated sludge based processes

Microalgae biotechnology is a promising tool for many applications, including the elimination of nutrients and other contaminants from wastewater. In this work, we measured the removal efficiency of two wastewater treatment processes: an activated-sludge based conventional process and another based on microalgae biotechnology using high-rate algae ponds (HRAPs). The latter was tested using two different configurations. In the first one, HRAPs were placed after an UASB reactor and used as a tertiary treatment to remove nutrients. In the second, the UASB reactor was disconnected so the HRAPs were directly fed with pretreated wastewater. Additional treatment was performed using dissolved air flotation (DAF). The performances of both configurations (UASB-HRAP and HRAP-DAF) were compared to that of the conventional line including primary and secondary biological treatments and operating in parallel within the same wastewater treatment plant (WWTP). Sixty-four out of 81 target PhACs were detected in the influent of the WWTP, at an average concentration of 223 μg L^-1, whereas 55 and 54 were measured in the conventional (14 μg L^-1) and non-conventional (17 μg L^-1) effluents. Average removal efficiencies were similar (94 vs. 92%) for both treatment lines when comparing total PhACs concentrations. The compositional patterns of the resulting effluents, however, were not, suggesting the occurrence of differential removal mechanisms depending on the chemicals and wastewater treatments considered. Highly consumed compounds such as ibuprofen and acetaminophen were predominant in the non-conventional effluent (>1 μg L^-1), denoting lower removal than in the conventional line. On the other hand, elimination of diclofenac and some specific antibiotics and diuretics (e.g., hydrochlorothiazide) was between 15 and 50% higher using HRAPs. Overall, the efficiency of the microalgae technology removing PhACs was found to be comparable to that used in conventional WWTPs. This, combined with a higher efficiency removing nutrients, shows the potential of HRAP technology for wastewater treatment as an alternative (or addition as tertiary treatment) to more conventional approaches based on activated sludge.